Подобный материал:
- Российские рекомендации Разработаны Комитетом экспертов Всероссийского научного общества, 1075.77kb.
- Рекомендации Российского медицинского общества по артериальной гипертонии и Всероссийского, 820.04kb.
- Научная программа организационный комитет почетный председатель съезда оганов Рафаэль, 391.06kb.
- Национальные рекомендации по диагностике и лечению артериальной гипертензии Всероссийское, 609.76kb.
- Отчет о работе iii-й Всероссийской конференции кардиоваскулярная профилактика и реабилитация, 81.18kb.
- Квалификационные тесты по анестезиологии и реаниматологии (полный список), 1728.3kb.
- Доклад Рабочей группы по Глобальному партнерству "Группы восьми", 611.74kb.
- Доклад о работе рабочей группы, 117.21kb.
- Доклад Рабочей группы для Генеральной Ассамблеи оон, 2008, 102.18kb.
- Европейского Кардиологического Общества по лечению больных острыми коронарными синдромами, 941.24kb.
The Renal Arterial Resistance Index and Renal Allograft Survival // N. Engl. J. Med. – 2003. – V.349(2). – P.115-124.
Rivolta R., Cardinale L., Lovaria A., Di Palo F.Q. Variability of renal echo-Dopler measurements in healthy adults // J. Nephrol. – 2000. – V.13.
Roberts J.M. Endothelial dysfunction in preeclampsia // Semin. Reprod. Endocrinol. – 1998. – V.16. – P.5-15.
Roberts J.M., Pearson G., Cutler J., Lindheimer M. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy // Hypertension. – 2003. – V.41. – P.437.
Roberts J.M., Redman C.W. Pre-eclampsia: more than pregnancy–induced hypertension // Lancet. – 1993. – V.341. – P.1447-1451.
Roberts J.M., Taylor R.N., Musci T.J. et al. Preeclampsia: an endothelial cell disorder // Am. J. Obstet. Gynecol. – 1989. – V.161. – P.1200-1204.
Rodie V.A., Freeman D.J., Sattar N., Greer I.A. Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy? // Atherosclerosis. – 2004. - 175(2). – P.189-202.
Romundstad S., Holmen J., Kvenild K. et al. Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trondelag Health Study (HUNT), Norway // Am. J. Kidney Dis. – 2003. – V.42(3). – P.466-473.
Ross-McGill H., Hewison J., Hirst J. et al. Antenatal home blood pressure monitoring: a pilot randomised controlled trial. //BJOG. - 2000. – V.107. - P. 217-221.
Rudnicki M., Frolich A., Pilsgaard K. et al. Comparison of magnesium and methyldopa for the control of blood pressure in pregnancies complicated with hypertension // Gynecol. Obstet. Investig. – 2000. – V.49(4). – P.231-235.
Saji H., Yamanaka M., Hagiwara A., Ijiri R. Losartan and fetal toxic effects // Lancet. – 2001. – V.357. – P.363.
Sala C., Campise M., Ambroso G. Atrial Natriuretic Peptide and Hemodynamic Changes During Normal Human Pregnancy // Hypertension. – 1995. – V.25. – P.631-636.
Salas S.P. What causes preeclampsia? // Baillieres. Best Pract. Res. Clin. Obstet. Gynecol. – 1999. – V.13. – P.41-57.
Sattar N., Greer I.A. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? // BMJ. – 2002. – V.325. – P.157-160.
Savvidou M.D., Donald A.E., Nicolaides K.H. Assessment of endothelial function in normal twin pregnancy // Ultrasound Obstet. Gynecol. - 2001. - V.17 (3). - P. 220-223.
Savvidou M.D., Vallance P.J.T., Nicolaides K.H., Hingorani A.D. Endothelial Nitric Oxide Synthase Gene Polymorphism and Maternal Vascular Adaptation to Pregnancy // Hypertension. - 2001. - V.38 (6). - P. 1289.
Schannwell C.M., Schneppenheim M., Plehn G. et al. Left ventricular diastolic function in physiologic and pathologic hypertrophy // Am. J. Hypertens. – 2002. – V.15 (6) – P.513-517.
Schannwell C.M., Zimmermann T., Schneppenheim M. et al. Left ventricular hypertrophy and diastolic dysfunction in healthy pregnant women // Cardiology. – 2002. – V.97 (2). – P.73-78.
Schillaci G., Verdecchia P., Porcellati C. et al. Continuousation between left ventricular mass and risk in essential hypertension // Hypertension. – 2000. – V.35. –P.580-586.
Seely E.W., Solomon C.G. Insulin Resistance and its potential role in pregnancy-induced hypertension // J. Clin. Endocrin. Metabol. – 2003. – V.88(3). – P. 2393-2398.
Serra-Serra V., Kyle P.M., Chandran R., Redman C.W. The effect of nifedipine and methyldopa on maternal cerebral circulation // BJOG. – 1997. – V.104(5). – P.532-537.
Sibai B.M. Diagnosis and management of gestational hypertension and preeclampsia // Obstet. Gynecol. – 2003. – V.102. – P.181-192.
Sibai B.M., el-Nazer A., Gonzalez-Ruiz A. et al. Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis // Am. J. Obstet. Gynecol. – 1986. – V.155(5). – Р.1011-1016.
Sibai B.M. Treatment of hypertension in pregnant women // New Eng. J. Med. – 1996. – V. 335. – P. 257-265.
Simmons L.A., Gillin A.G., Jeremy R.W. Structural and functional changes in left ventricle during normotensive and preeclamptic pregnancy // Am. J. Physiol. Heart Circ. Physiol. – 2002. – V.283 (4). – P. 1627-1633.
Smith G.C., Pell J.P., Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births // Lancet. – 2001. – V.357. - Р.2002–2006.
Soldo D., Brkljacic B., Bozikov V. et al. Diabeic nephropathy. Comparison of conventional and duplex Doppler ultrasonographic findings // Acta Radiol. – 1997. – V.38(2). – P.296-302.
Sorensen K.E., Celermajer D.S., Spiegelhalter D.J. et al. Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility // British Heart J. – 1995. – V.74. – P.247-253.
Sorensen T.K., Hendricks S., Easterling T.R., et al. Effect of orthoststic stress on umbilical Doppler waveforms in normal and hypertensive pregnancies // Am. J. Obstet. Gynec. – 1992. – V.167(3). – P.643-647.
Spaanderman M.E.A., Meertens M., van Bussel M. et al. Cardiac output increases independently of basal metabolic rate in early human pregnancy // Am. J. Physiol. Heart Circ. Physiol. – 2000. – V.278 (5). – P.1585-1588.
Splendiani G. , Parolini C., Fortunato L. et al. Resistive index in chronic nephropathies: predictive value of renal outcome // Clinical Nephrology. – 2002. – V.57(1). – P.45-50.
Stehouwer C.D., Fischer H.R., van Kuijk A.W. et al. Endothelial dysfunction precedes development of microalbuminuria in IDDM // Diabetes. - 1995. - V. 44(5). - P. 561-564.
Sturgiss S.N., Martin K., Whittigham A., Davison J.M. Assessment of renal circulation during pregnancy with color Doppler ultrasonografy // Am. J. Obstet. Gynec. – 1992. – V.167(5). – P.1250-1254.
Taddei S., Virdis A., Ghiadoni L., Salvetti A. The role of endothelium in human hypertension // Curr. Opin. Nephrol. Hypertension. – 1998. – V.7. – P.203-209.
Taddei S., Virdis A., Mattei P. et al. Lack of correlation between microalbuminuria and endothelial function in essential hypertensive patients // J. Hypertension. – 1995. – V.13. – P.1003-1008.
Taddei S., Virdis A., Mattei P., Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension // Hypertension. – 1993. – V.21. – P.929-933.
Tenhola S., Rahiala E., Martikainen A. et al. Blood pressure, serum lipids, fasting insulin, and adrenal hormones in 12-year-old children born with maternal preeclampsia // J. Clin. Endocrinol. Metab. – 2003. – V.88(3). – P.1217-1222.
Thaler I., Amit A., Kamil D., Itskovitz-Eldor J. The effect of isosorbide dinitrate on placental blood flow and maternal blood pressure in women with pregnancy induced hypertension // Am. J. Hypertens. – 1999. – V.12(4). – P.341-347.
Thaler I., Weiner Z., Itskovitz J. Renal artery flow velocity waveforms in normal and hypertensive pregnant woman // Am. J. Hypertens. - 1992. – V.6(1). – P.402-405.
The MAGPIE Trial Collaborative Group. Do women with preeclampsia, and their babies, benefit from magnesium sulphate? The MAGPIE Trial: a randomized placebo controlled trial // Lancet. – 2002. – V.359. – P.1877-1889.
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure // Hypertension. – 2003. – V.42. – P.1206-1256.
The Task Force on the Management of Cardiovascular Diseases During Pregnancy on the European Society of Cardiology. Expert consensus document on management of cardiovascular diseases during pregnancy // Eur. Heart J. – 2003. – V.24. – P.761-781.
Tsioufis C., Stefanadis C., Toutouzas M. et al. Microalbuminuria is associated with unfavourable cardiac geometric adaptations in essential hypertensive subjects // J. Hum. Hypertens. – 2002. – V.16. – P.249-254.
Tzemos N., Lim P.O., MacDonald T.M. Nebivolol Reverses Endothelial Dysfunction in Essential Hypertension. A Randomized, Double Blind, Crossover Study // Circulation. – 2001. – V. 104(5). – P. 511-514.
Uehata A., Gerhard M.D., Mezerdith I.T. et al. Close relationship of endothelial dysfunction in coronary and brachial artery // Circulation. – 1993. – V.88. – P.611-618.
Vakili B., Okin P.M., Devereux R.B. Prognostic implications of left ventricular hypertrophy // Am. Heart J. – 2001. – V.141. – P.334-341.
Valensise H., Novelli G.P., Vasapollo B. et al. Maternal Diastolic Dysfunction and Left Ventricular Geometry in Gestational Hypertension // Hypertension. – 2001. – V.37. – P.1209.
Van Bortel L., Struijker-Boudier H., Safar M.E. Pulse pressure, arterial stiffness, and drug treatment of hypertension // Hypertension. – 2001. – V.38. – P.914.
Vanhoutte P.M., Boulanger C.M., Mombouli J.V. Endothelium-derived relaxing factors and converting enzyme inhibition // Am. J. Cardiol. – 1995. – V.76. – P.3-12.
Van Nueten L., Taylor F.R., Robertson J.I.S. Nebivolol vs atenolol and placebo in essential hypertension: a double-blind randomized trial // J. Hum. Hypertens. – 1998. – V.12. – P.135-140.
Varela A.F., Runge A., Ignarro L.J., Chaudhur G. Nitric oxide and prostacyclin inhibit fetal platelet aggregation: a respons similar to that observed in adults // Am. J. Obstet. Gynecol. - 1992. - V.167 (2). - P. 1599-1604.
Vedernikov Y., Saade G.R., Garfield R.E. Vascular reactivity in preeclampsia // Semin. Perinatol. – 1999. – V.23. – P.34-44.
Veille J.C., Bissonette J.M., Hohimer A.R. The effect of a calcium channel blocker (nifedipin) of uterine blood flow in the pregnant goat // Am. J. Obstet. Gynecol. – 1986. – V.154(5). – P.1160-1163.
Vermillion S.T., Scardo J.A., Newman R.B., Chauhan S.P. A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy // Am. J. Obstet. Gynecol. – 1999. – V.181(4). – P.858-861.
Viberti G.C., Mogensen C.E., Passa P. et al. St. Vincent Declaration 1994: guidelines for the prevention of diabetic renal failure. In: Mogensen C.E., ed. The kidney and hypertension in diabetes mellitus, 2nd ed. Boston: Dordrecht/London: Kluwer, 1994. - P.515-527.
Viberti G., Pickup J.C., Bilous R.W. et al. Correction of exercise-induced microalbuminuria in insulin-dependent diabetics after 3 weeks of subcutaneous insulin infusion // Diabetes. – 1981. – V.30. – P.818-823.
Von Dadelszen P., Ornstein M.P., Bull S.B. et al. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis // Lancet. – 2000. – V.355. - P.87-92.
Wachtell K., Ibsen H., Olsen M.H. et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study // Ann. Intern. Med. – 2003. - V.139. – P.901-906.
Wagner L.K. Diagnosis and Management of Preeclampsia // J. Am. Fam. Physic. – 2004. – V.70(12). – P.2317-2324.
Walker J.J., Mathers A., Bjornssons. The effect of acute and chronic antihypertensive therapy on maternal and fetoplacental Doppler velocimetry // Eur. J. Obstet. Gynecol. Reprod. Biol. – 1992. – V.43(3). – P.193-199.
Wang Y., Walsh S.W., Kay H.H. Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia // Am. J. Obstet. Gynecol. – 1992. - V.167. – P.946-949.
Weir M.R. Angiotensin II Receptor Blockers: The Importance of Dose in Cardiovascular and Renal Risk Reduction // J. Clin. Hypertens. – 2004. – V.6. – P.315-325.
Weiner C.P., Knowles R.G., Moncada S. Induction of nitric oxide synthases early in pregnancy // Am. J. Obstet. Gynecol. – 1994. – V.171. – P.838-843.
Weitz C., Khouzami V., Maxwell K., Johnson J.W.C. Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study // Int. J. Gynecol. Obstet. – 1987. – V.25. – P.35-40.
Wichman K., Ryulden G., Karberg B.E. A placebo-controlled trial of metoprolol in the treatment of hypertension in pregnancy // Scand. J. Clin. Lab. Invest. – 1984. – V.169. – P.90-94.
Williams D. Pregnancy: a stress test for life // Curr. Opin. Obstet. Gynecol. – 2003. – V.15(6). – P.465-471.
Williams D., Vallance P.J., Neild G.H. et al. Nitric oxide-mediated vasodilation in human pregnancy // Am. J. Physiol. Heart Circ. Physiol. – 1997. – V.272 (2). – P. 748-752.
Williams M.R.I., Westerman R.A., Kingwell B.A. et al. Variations in Endothelial Function and Arterial Compliance during the Menstrual Cycle // J. Clin. Endocrin. Metabol. – 2001. - V.86(11). – P.5389-5395.
Wilson B.J., Watson M.S., Prescott G.J. et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study // BMJ. – 2003. – V.326. – P.845.
Wisenbaugh T., Katz I., Davis J. Long-Term (3-month) Effects of a New Beta-Blocker (Nebivolol) on Cardiac Performance in Dilated Cardiomyopathy // JACC. – 1993. – V.21(5). – P.1094-1100.
Woo K.S., Chook P., Lolin Y.I. et al. Hyperhomocystinemia is a risk factor for arterial endothelial dysfunction in humans // Circulation. – 1997. – V.96. – P.2542–2544.
Yeo S., Steele N.M., Chang M.C. et al. Effect of exercise on blood pressure in pregnant women with a high risk of gestational hypertensive disorders // J. Reprod. Med. – 2000. –V.45. – P. 293-298.
Yoshida A., Nakao S., Kobayashi M., Kobayashi H. Flow-Mediated Vasodilatation and Plasma Fibronectin Levels in Preeclampsia // Hypertension. - 2000. - V. 36(3). - P.400–404.
Yoshida A., Nakao S., Kobayashi H. et al. Noninvasive assessment of flow-mediated vasodilation with 30-MHz transducer in pregnant women // Hypertension. - 1998. – V.31. - P.1200-1201.
Yuyun M.F., Khaw K.T., Luben R. et al. Microalbuminuria and stroke in a British Population: the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study // J. Intern. Med. – 2004. – V.255(2). – P.247-256.
Yuyun M.F., Khaw K.T., Luben R. et al. A Prospective Study of Microalbuminuria and Incident Coronary Heart Disease and Its Prognostic Significance in a British Population. The EPIC-Norfolk Study // Am. J. Epidemiol. – 2004. – V.159(3). – P.284-293.
Zhang J., Meikle S., Trumble A. Sever maternal morbidity associated with hypertensive disorders in pregnancy in the United States // Hypertens. Pregnancy. – 2003. – V.22. – P. 203-212.
Клинические рекомендации. Акушерство и гинекология / под. Ред. В.И. Кулакова. – М.: ГЭОТАР-Медиа, 2006.- 512 с.
Баранова Е.И. Артериальная гипертензия у беременных //Артериальная гипертензия. – 2006. – Т.12, № 1. – С.7-15.
Карпов О.И., Зайцев А.А. Риск применения лекарственных препаратов при беременности и лактации. – СПб.: «издательство Диля», 2003. – 352 с.
Маслова Н.П., Баранова Е.И. Гипертоническая болезнь у женщин. – СПб.: Издательство СПбГМУ, 2000. – 216 с.
Pre-eclampsia Community Guideline (PRECOG) //BMJ – 2005. – Vol.330, N 7491. – P.576-580.
